Chronic lower back pain is something that can dramatically affect a person’s lifestyle and wellbeing. Whilst most back pain only lasts a short while and can be treated with medication or physiotherapy, for others it can be ongoing and negatively affect their everyday life.
When the usual treatments don’t work, it can feel like there’ll never be a solution for the pain. Thanks to advancements in medical technology, however, Teesside patients may now finally be able to find a solution to their chronic low back pain.
ReActiv8 was introduced in 2019 to South Tees Hospitals NHS Trust. Since its introduction, the therapy has been used in 16 cases of patients with chronic low back pain. Patients wishing to be considered for the ReActiv8 therapy should contact [email protected] .
How does the ReActiv8 therapy work?
ReActiv8 is designed to help patients who have not responded to other methods of treatments, like medicines and physical therapy. The small implantable device has two leads that are positioned outside your spine, next to the dorsal ramus nerves that control your spine’s stabilizing muscles.
In patients with mechanical chronic low back pain, impaired muscle control may arise after even a single incidence of injury to the low back. To avoid pain, the brain automatically limits activation of the most important stabilizing muscle of the low spine, the multifidus muscle.
This reduced muscle activation can cause spine segments to shift into painful positions from sudden or abnormal movements. If not resolved, this can evolve into a debilitating cycle of pain, poor muscle activation and muscle weakness. This lack of muscle control and neural inhibition decreases functional stability of the spine, which can leave the spine susceptible to further injury and overloading.
ReActiv8 overcomes neural inhibition and allows the body to regain control of the multifidus, allowing it to provide functional lumbar stability and reduce mechanically-based pain. By stimulating the innervating nerves (e.g., the medial branch of the dorsal ramus) of the multifidus directly, this efficient, effective therapy can be delivered with minimal effort by the patient and provider.
Rather than masking the pain with medication or other palliative treatments, ReActiv8 is designed to improve neuromuscular control of the lumbar spine and reduce pain. ReActiv8 clinical studies show that up to 77% of patients improve their pain and/or disability by at least 50%. 1
“This therapy is for a select group of patients whose back pain is due to a specific back muscle dysfunction. Indeed, we have had great results in terms of pain relief and functional improvement in this group of patients,” says Dr Gulve of South Tees Hospital.
Dr Gulve’s patient, Rachel, received ReActiv8 in 2018. Within her first year, she saw significant improvements in her functional ability. After three years with the therapy, she continues to experience an increase in function and decrease in pain. Watch Rachel’s Story:
How can I get the ReActiv8 therapy?
The therapy is funded by the NHS and readily available on the NHS framework. That means patients around the country can benefit from ReActiv8 device.
Patients wishing to be considered for the ReActiv8 implant can contact [email protected] . You’ll be able to discuss the therapy further and find out how to gain access to it.
To learn more about ReActiv8 visit www.mainstaymedical.com
1. Gilligan C., Volschenk W., Russo M., et al Long-Term Outcomes of Restorative Neurostimulation in Patients With Refractory Chronic Low Back Pain Secondary to Multifidus Dysfunction: Two-Year Results of the ReActiv8-B Pivotal Trial Neuromodulation Available online 3 January 2022 https://doi.org/10.1016/j.neurom.2021.10.011
Indications for Use: ReActiv8 is an adjunct to medical management of Chronic Low Back Pain for relief of pain in adults who have attempted at least medical management and physical therapy.
Carefully read all contraindications, warnings, precautions, considerations for patient selection and instructions before use. Follow all operating, maintenance, and installation procedures as described in the manual. Failure to do so may result in patient or operator harm. Safety may be compromised if the procedures used to operate and maintain the ReActiv8 system are different than those specified in the manuals. Anyone who performs the procedures must be appropriately trained and qualified. Refer to www.mainstaymedical.com/safety for important safety information.